Akebia Therapeutics (AKBA) EPS (Basic) (2013 - 2026)
Akebia Therapeutics' (AKBA) quarterly EPS (Basic) came in at -$0.03 in Q1 2026, down 230.63% year-on-year from $0.03 in Q1 2025, and up 28.79% on a QoQ basis from -$0.05 in Q4 2025.
Akebia Therapeutics (AKBA) EPS (Basic) (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has 14 years of EPS (Basic) data on file, last reported at -$0.03 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 230.63% year-over-year to -$0.03 in Q1 2026; TTM through Mar 2026 was -$0.08, a 60.08% increase from a year earlier, with the FY2025 full-year figure at -$0.02, up 93.68% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.03, up from -$0.05 in the prior quarter.
- Over the last five years, EPS (Basic) for AKBA reached as high as $0.16 in Q2 2022 and fell as low as -$0.35 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.07 across 5 years, with a median of -$0.05 in 2025.
- Across the five-year window, EPS (Basic) soared 131.16% in 2022 and plunged 3400.59% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$0.02 in 2022, then soared by 114.52% to $0.0 in 2023, then plunged by 3400.59% to -$0.11 in 2024, then surged by 55.96% to -$0.05 in 2025, then rose by 28.79% to -$0.03 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.03 in Q1 2026, -$0.05 in Q4 2025, and $0.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | Akebia Therapeutics | 325.80 Mn | 163.20 Mn | 41.25 Mn | -0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03 |
| Dec 31, 2025 | -0.05 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.10 |
| Jun 30, 2024 | -0.04 |
| Mar 31, 2024 | -0.09 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.06 |
| Mar 31, 2023 | -0.15 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | -0.29 |
| Jun 30, 2022 | 0.16 |
| Mar 31, 2022 | -0.35 |
| Dec 31, 2021 | -0.41 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | -0.51 |